455 Mission Bay Boulevard South, C/O Nektar Therapeutics, San Francisco, CA
Summary
The estimated net worth of Jonathan Zalevsky is at least $1.03M dollars as of November 25, 2025. Jonathan Zalevsky is the Chief R&D Officer of NEKTAR THERAPEUTICS and owns shares of NEKTAR THERAPEUTICS (NKTR) stock worth about $1.03M.
Insider Transactions Reported by Jonathan Zalevsky:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.